These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9357393)

  • 1. Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers.
    Kazierad DJ; Martin DE; Blum RA; Tenero DM; Ilson B; Boike SC; Etheredge R; Jorkasky DK
    Clin Pharmacol Ther; 1997 Oct; 62(4):417-25. PubMed ID: 9357393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.
    Yasar U; Forslund-Bergengren C; Tybring G; Dorado P; Llerena A; Sjöqvist F; Eliasson E; Dahl ML
    Clin Pharmacol Ther; 2002 Jan; 71(1):89-98. PubMed ID: 11823761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers.
    Tenero DM; Martin DE; Ilson BE; Boyle DA; Boike SC; Carr AM; Lundberg DE; Jorkasky DK
    Ann Pharmacother; 1998 Mar; 32(3):304-8. PubMed ID: 9533060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.
    Martin DE; Chapelsky MC; Ilson B; Tenero D; Boike SC; Zariffa N; Jorkasky DK
    J Clin Pharmacol; 1998 Feb; 38(2):129-37. PubMed ID: 9549643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers.
    Williamson KM; Patterson JH; McQueen RH; Adams KF; Pieper JA
    Clin Pharmacol Ther; 1998 Mar; 63(3):316-23. PubMed ID: 9542475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.
    Fischer TL; Pieper JA; Graff DW; Rodgers JE; Fischer JD; Parnell KJ; Goldstein JA; Greenwood R; Patterson JH
    Clin Pharmacol Ther; 2002 Sep; 72(3):238-46. PubMed ID: 12235444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose proportionality study of eprosartan in healthy male volunteers.
    Chapelsky MC; Martin DE; Tenero DM; Ilson BE; Boike SC; Etheredge R; Jorkasky DK
    J Clin Pharmacol; 1998 Jan; 38(1):34-9. PubMed ID: 9597557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender.
    Xu HR; Chen WL; Li XN; Liu GY; Chu NN; Yu C
    Pharmazie; 2007 Oct; 62(10):782-4. PubMed ID: 18236785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food.
    Tenero D; Martin D; Ilson B; Jushchyshyn J; Boike S; Lundberg D; Zariffa N; Boyle D; Jorkasky D
    Biopharm Drug Dispos; 1998 Sep; 19(6):351-6. PubMed ID: 9737815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.
    Li Z; Wang G; Wang LS; Zhang W; Tan ZR; Fan L; Chen BL; Li Q; Liu J; Tu JH; Hu DL; Liu ZQ; Zhou HH
    Xenobiotica; 2009 Oct; 39(10):788-93. PubMed ID: 19604036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical pharmacology of losartan in Japanese subjects and patients.
    Nakashima M; Umemura K
    Blood Press Suppl; 1996; 2():62-6. PubMed ID: 8913542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age and gender on the pharmacokinetics of eprosartan.
    Tenero DM; Martin DE; Miller AK; Ilson B; Boike SC; Zariffa N; Jorkasky DK
    Br J Clin Pharmacol; 1998 Sep; 46(3):267-70. PubMed ID: 9764969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus.
    Moon CH; Lee HJ; Jung YS; Lee SH; Baik EJ
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):147-58. PubMed ID: 9821211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negligible Pharmacokinetic Interaction of Red Ginseng and Losartan, an Antihypertensive Agent, in Sprague-Dawley Rats.
    Ryu SH; Kim YS; Jang HJ; Kim KB
    J Toxicol Environ Health A; 2015; 78(20):1299-309. PubMed ID: 26514876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
    Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
    Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatic disease on the pharmacokinetics and plasma protein binding of eprosartan.
    Tenero D; Martin D; Chapelsky M; Ilson B; Boike S; Patterson S; Keogh J; Rodriguez S; Jorkasky D
    Pharmacotherapy; 1998; 18(1):42-50. PubMed ID: 9469680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers.
    Zaidenstein R; Soback S; Gips M; Avni B; Dishi V; Weissgarten Y; Golik A; Scapa E
    Ther Drug Monit; 2001 Aug; 23(4):369-73. PubMed ID: 11477318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of eprosartan pharmacokinetic and pharmacodynamic drug interaction studies.
    Blum RA; Kazierad DJ; Tenero DM
    Pharmacotherapy; 1999 Apr; 19(4 Pt 2):79S-85S. PubMed ID: 10213526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease.
    Kovacs SJ; Tenero DM; Martin DE; Ilson BE; Jorkasky DK
    Pharmacotherapy; 1999 May; 19(5):612-9. PubMed ID: 10331824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.